AVROBIO (AVRO) News Today → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free AVRO Stock Alerts $1.26 +0.01 (+0.80%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAVROBIO (NASDAQ:AVRO) Trading 1.6% Higher americanbankingnews.com - May 7 at 2:24 AMDeal watch: Biopharma M&A more than doubled in Q1bizjournals.com - April 22 at 9:32 AMShort Interest in AVROBIO, Inc. (NASDAQ:AVRO) Rises By 14.6%marketbeat.com - April 14 at 1:27 PMAVROBIO Inc.wsj.com - March 26 at 9:48 AMAVROBIO (AVRO) Scheduled to Post Quarterly Earnings on Thursdaymarketbeat.com - March 20 at 7:46 AMAVROBIO, Inc. (NASDAQ:AVRO) Short Interest Updatemarketbeat.com - March 3 at 10:46 AMAVROBIO, Inc. (NASDAQ:AVRO) Short Interest Down 30.3% in Februarymarketbeat.com - March 1 at 10:13 PMAVRO Apr 2024 2.500 callca.finance.yahoo.com - February 23 at 10:19 AMAVRO May 2024 2.500 callfinance.yahoo.com - February 18 at 3:19 PMAVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRObusinesswire.com - February 14 at 11:11 AMShareholder Alert: Ademi LLP investigates whether AVROBIO, Inc. has obtained a Fair Price in its transaction with Tectonicstockhouse.com - January 31 at 5:53 PMFive things: Vertex's new drug, a reverse merger, and how are you doing?bizjournals.com - January 31 at 7:52 AMAvrobio Inc Announces Executive Team Changes and Appointmentsmsn.com - January 31 at 7:52 AMAvrobio to take Watertown biotech public via reverse mergerbizjournals.com - January 30 at 9:52 PMSHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AVRO, CALB, BCALstockhouse.com - January 30 at 4:52 PMAvrobio to buy 100% equity interests of Tectonic Therapeuticmsn.com - January 30 at 4:52 PMAvrobio Shares Dive 17% After Tectonic Therapeutic Dealmarketwatch.com - January 30 at 4:52 PMAVROBIO and Tectonic Therapeutic Announce Mergerfinance.yahoo.com - January 30 at 9:38 AMmarketbeat.com - January 30 at 7:56 AMAvrobio Stock (NASDAQ:AVRO), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 20 at 12:32 AMMizuho Downgrades AVROBIO (AVRO)msn.com - December 19 at 7:31 PMAvrobio Stock (NASDAQ:AVRO) Dividends: History, Yield and Datesbenzinga.com - December 19 at 4:27 AMAvrobio just downgraded at Mizuho, here's whyrealmoney.thestreet.com - December 18 at 4:11 PMAvrobio Inc AVROmorningstar.com - November 14 at 8:36 AMPotential Growth and Strategic Alternatives: Reasons Behind Zhu’s Buy Rating for Avrobiomarkets.businessinsider.com - November 14 at 8:36 AMIs AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - November 8 at 2:26 PMHas AVROBIO (AVRO) Outpaced Other Medical Stocks This Year?finance.yahoo.com - October 6 at 1:36 PMAvroBio (AVRO) Price Target Increased by 12.82% to 3.74msn.com - October 5 at 9:47 AMAVROBIO, Inc. (AVRO)ca.finance.yahoo.com - September 25 at 1:50 PMSolu Therapeutics Appoints Philip Vickers, Ph.D., as President and Chief Executive Officerbenzinga.com - September 11 at 9:46 AMAvrobio: Net-Net Biotech Pursuing Strategic Alternativesmsn.com - August 12 at 7:24 AMAvrobio (AVRO) Gets a Buy from Barclaysmarkets.businessinsider.com - August 11 at 6:35 AMArbor Biotechnologies Appoints Deanna M. Petersen as Chief Business Officerfinance.yahoo.com - August 7 at 12:10 PMWells Fargo Maintains AvroBio (AVRO) Overweight Recommendationnasdaq.com - July 13 at 10:53 PMAVROBIO (AVRO) to Explore Strategic Options, Stock Rises 46%finance.yahoo.com - July 13 at 12:43 PMFive things you need to know today, and the Sumner Tunnel closure’s real testbizjournals.com - July 13 at 7:43 AMWedbush Downgrades Avrobio to Neutral, Announces $2 Price Targetbenzinga.com - July 12 at 8:38 PMAvrobio to explore strategic options; halts studiesseekingalpha.com - July 12 at 8:38 PMWhy Avrobio Shares Are Rising Wednesdaymsn.com - July 12 at 8:38 PMAvrobio Shares Rise 38% After Move to Explore Strategic Alternativesmarketwatch.com - July 12 at 8:38 PMWedbush Downgrades AvroBio (AVRO)msn.com - July 12 at 8:38 PMGene therapy startup Avrobio explores a salebizjournals.com - July 12 at 3:37 PMAVROBIO To Conduct Exploration Of Strategic Alternatives - Quick Factsmarkets.businessinsider.com - July 12 at 8:16 AMAVROBIO to Explore Strategic Alternativesfinance.yahoo.com - July 12 at 8:16 AMmarketbeat.com - July 12 at 6:55 AMAVRO - AVROBIO, Inc.finance.yahoo.com - June 28 at 12:52 AMAvrobio (NASDAQ: AVRO)fool.com - June 27 at 9:50 AMAvrobio completes sale of gene therapy program to Novartis for $87.5Mseekingalpha.com - June 12 at 7:12 PMAVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Millionfinance.yahoo.com - June 12 at 7:12 PMAvrobio, Cardiff Oncology top healthcare gainers; Vaxart, Carisma among losersmsn.com - June 7 at 10:52 AM Get AVROBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for AVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here AVRO Media Mentions By Week AVRO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVRO News Sentiment▼0.000.36▲Average Medical News Sentiment AVRO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVRO Articles This Week▼11▲AVRO Articles Average Week Get AVROBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for AVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cidara Therapeutics News Today Genenta Science News Today Entera Bio News Today Aligos Therapeutics News Today LENZ Therapeutics News Today Turnstone Biologics News Today Quince Therapeutics News Today OKYO Pharma News Today Ikena Oncology News Today Cyclo Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVRO) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVROBIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
